Cosán and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults
Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually.
Kevin Love & Genomind Join Forces to Introduce a New Expert Starting Point for Mental Wellness
Kevin Love partners with Genomind to introduce Mental Health Map, a genetic test designed to help people start their mental health and wellness journey.
Genomind and Stop Soldier Suicide Partner in Mission to Reduce Soldier and Veteran Suicides
Genomind and Stop Soldier Suicide Partner in Mission to Reduce Soldier and Veteran Suicides
Genomind Partners with NeuroFlow, Transforming Model of Care for Mental Health Patients
Genomind Partners with NeuroFlow, Transforming Model of Care for Mental Health Patients.
Standard Process Partners With Genomind® To Offer Mindful DNA – A Breakthrough In Personalized Wellness
Standard Process Partners With Genomind® To Offer Mindful DNA – A Breakthrough In Personalized Wellness.
Personalized Medicine Advances With First-of-its-Kind Partnership between Genomind® and Albertsons Sav-On, Jewel-Osco and Acme Sav-On
Personalized Medicine Advances With First-of-its-Kind Partnership between Genomind® and Albertsons Sav-On, Jewel-Osco and Acme Sav-On.
ValueOptions And Genomind Announce Innovative Study Of Pharmacogenomic Testing For Treating Psychotic Disorders
ValueOptions And Genomind Announce Innovative Study Of Pharmacogenomic Testing For Treating Psychotic Disorders
Genomind’s Genetic Testing At Princeton House Promotes Personalized Care
Genomind’s Genetic Testing At Princeton House Promotes Personalized Care
Genomind Announces Licensing Agreement With Emory University To Commercialize Novel Alzheimer’s Risk Biomarkers
Genomind Announces Licensing Agreement With Emory University To Commercialize Novel Alzheimer’s Risk Biomarkers
Genomind Supports Neuroscience Education Institute (NEI) With Grant To Further Knowledge Of Personalized Medicine Among Health Professionals
Genomind Supports Neuroscience Education Institute (NEI) With Grant To Further Knowledge Of Personalized Medicine Among Health Professionals
Genomind Supports Massachusetts General Hospital (MGH) Psychiatry Academy With Grant For Live Learning Symposium On Biomarkers In Psychiatry
Genomind Supports Massachusetts General Hospital (MGH) Psychiatry Academy With Grant For Live Learning Symposium On Biomarkers In Psychiatry
Centerstone And Genomind Begin New Study On Genetic Test For Patients With Major Depressive Disorder
Centerstone And Genomind Begin New Study On Genetic Test For Patients With Major Depressive Disorder
Genomind Announces Inpatient Study With Massachusetts General Hospital Of Genetic Biomarkers In Treatment Resistant Depression
Genomind Announces Inpatient Study With Massachusetts General Hospital Of Genetic Biomarkers In Treatment Resistant Depression
Genomind Education Grant To Neuroscience Education Institute (NEI) Explores Genotyping In Psychiatry
Genomind Education Grant To Neuroscience Education Institute (NEI) Explores Genotyping In Psychiatry
Data Collection Completed At Metrocare & Schlosspark
Data Collection Completed At Metrocare & Schlosspark
Genomind Joins Personalized Medicine Coalition
Genomind Joins Personalized Medicine Coalition
Genomind Lab Partner, PGXL, Selected By National PBM To Provide Tests
Genomind Lab Partner, PGXL, Selected By National PBM To Provide Tests
Genomind Announces Partnership with PGxL
Genomind Announces Partnership with PGXL
